Patient Assessment

References

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2017. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, l.: GOLD.
2. Celli, B. R. et al., 2004. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. The New England Journal of Medicine, 4 March, Volume 350, pp. 1005-1012.
3. Ong, K. C., Earnest, A. & Lu, S. j., 2005. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest, December, 128(6), pp. 3810-3816.
4. Cote, C. G. & Celli, B. R., 2005. Pulmonary rehabilitation and the BODE index in COPD. European Respiratory Journal, October, 26(4), pp. 630-636.
5. Singh , S. J. et al., 2014. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. European Respiratory Journal, December, 44(6), pp. 1447-1478.
6. Holland, A. E. et al., 2014. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. European Respiratory Journal, December, 44(6), pp. 1428-1446.
7. Jenkins, S. et al., 2009. Regression equations to predict 6-minute walk distance in middle-aged and elderly adults. Physiotherapy Theory and Practice, October, 25(7), pp. 516-522.
8. Singh, S. J., Jones, P. W., Evans, R. & Morgan, M. D., 2008. Minimum clinically important improvement for the incremental shuttle walk test. Thorax, September, 63(9), pp. 775-777.
9. Revill, S. et al., 1999. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax, March, 54(3), pp. 213-222.
10. Hill, K. et al., 2012. A simple method to derive speed for the endurance shuttle walk test. Respiratory Medicine, December, 106(12), pp. 1665-1670.
11. Wootton, S. L. et al., 2014. Estimating endurance shuttle walk test speed using the six-minute walk test in people with chronic obstructive pulmonary disease. Chronic Respiratory Disease, May, 11(2), pp. 89-94.
12. American Thoracic Society; American College of Chest Physicians, 2003. ATS/ACCP Statement on cardiopulmonary exercise testing. American Journal of Respiratory Critical Care Medicine, 15 January, 167(2), pp. 211-277.
13. Laviolette, L. et al., 2008. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax, 27 September, Volume 63, pp. 115-121.
14. McKeough, Z. J., Velloso, M., Lima, V. P. & Alison, J. A., 2016. Upper limb exercise training for COPD. Cochrane Database Systematic Review, 15 November, Volume 11.
15. Jones, P. W. et al., 2009. Development and first validation of the COPD Assessment Test. European Respiratory Journal, September, 34(3), pp. 648-654.
16. Jones, P; Jenkins, C; Bauerle, O; (on behalf of the CAT Development Steering group), 2012. The COPD Assessment Test healthcare professional user guide: expert guidance on frequently asked questions, l.: s.n.
17. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory & Critical Care Medicine. 2013;188(8):e13-64.
18. Janssen DJ, Spruit MA, Leue C, Gijsen C, Hameleers H, Schols JM, et al. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis. 2010;7(3):147-57.
19. Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr Opin Pulm Med. 2009;15(2):143-9.
20. Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2001;21(2):80-6.
21. Giardino ND, Curtis JL, Andrei AC, Fan VS, Benditt JO, Lyubkin M, et al. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respiratory Research. 2010;11:29.
22. Keil DC, Stenzel NM, Kuhl K, Vaske I, Mewes R, Rief W, et al. The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis. 2014;11(1):31-40.
23. Zoeckler N, Kenn K, Kuehl K, Stenzel N, Rief W. Illness perceptions predict exercise capacity and psychological well-being after pulmonary rehabilitation in COPD patients. Journal of Psychosomatic Research. 2014;76(2):146-51.
24. Reijnders T, Schuler M, Wittmann M, Jelusic D, Troosters T, Janssens W, et al. The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD. Respiratory Medicine. 2019;146:87-95.
25. George A. Margaritopoulos, Maria A. Kokosi & Athol U. Wells (2019) Diagnosing complications and comorbidities of fibrotic interstitial lung disease, Expert Review of Respiratory Medicine, 13:7, 645-658, DOI: 10.1080/17476348.2019.1632196
26. Holland AE, Fiore JF Jr, Bell EC, Goh N, Westall G, Symons K, Dowman L, Glaspole I. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology. 2014 Nov;19(8):1215-21. doi: 10.1111/resp.12360. Epub 2014 Aug 12. PMID: 25112470.